Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2500087	Dostarlimab注射液	dostarlimab	Injection	Biological Products(3.1)	Import Drug Application	2025-06-11	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline (Ireland) Ltd	view
JXSL2400197	Dostarlimab注射液	dostarlimab	Injection	Biological Products(2.2)	Import Drug Application	2024-10-18	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd	view
JXSL2400189	Dostarlimab注射液	dostarlimab	Injection	Biological Products(2.2)	Import Drug Application	2024-09-30	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd	view
JXSL2400106	Dostarlimab注射液	dostarlimab	Injection	Biological Products(2.2)	Import Drug Application	2024-05-31	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd	view
JXSL2400094	Dostarlimab注射液	dostarlimab	Injection	Biological Products(2.2)	Import Drug Application	2024-05-17	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd	view
JXSL2400095	Dostarlimab注射液	dostarlimab	Injection	Biological Products(2.2)	Import Drug Application	2024-05-17	GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd	view